Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches

Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches

Acute myeloid leukemia (AML) is characterized by an increasing number of clonal myeloid blast cells which are incapable of differentiating into mature leukocytes. AML risk stratification is based on genetic background, which also serves as a means to identify the optimal treatment of individual pati...

Full description

Bibliographic Details
Main Authors: Paul Dowling, Ciara Tierney, Katie Dunphy, Juho J. Miettinen, Caroline A. Heckman, Despina Bazou, Peter O’Gorman
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Proteomes
Subjects:
acute myeloid leukemia
biomarkers
immunoassay
mass spectrometry
proteomics
Online Access:https://www.mdpi.com/2227-7382/9/4/42

Internet

https://www.mdpi.com/2227-7382/9/4/42

Similar Items